Dr Christine Grew MSci, PhD, MBA, FTOPRA
RareGenix Partner, Regulatory Lead
Dr Christine Grew, PhD, MBA, can support your innovation from a regulatory perspective. With over 20 years experience in leading successful regulatory outcomes, Christine advises on how to get the best out of scientific advice meetings with regulators and navigate the complexities of the global regulatory environment.
Christine has worked for Top-10 Pharma including AbbVie, AstraZeneca, Pfizer & Novo Nordisk. Over her 20-year career in regulatory affairs, Christine has held various roles including heading AbbVie’s global clinical trial regulatory team, attended face-to- face meetings with regulators & also worked for contract manufacturers, research organisations and drug development consultancies. Christine is a fractional chief regulatory officer for a start-up and was awarded TOPRA fellowship in 2024 for her distinguished contribution to regulatory affairs. Christine has worked across a broad range of therapeutic areas from early development to registration procedures, to post licensing activities with a focus on the US, EU and UK.
- Support for regulatory procedures IND, CTA, NDA, ANDA, BLA, MAA, eCTD, ODD, PRIME and BTD
- TOPRA Clinical Trial Special Interest Network Chair and Introductory Course Working Party Member
Contact
Feel free to reach out if you want to collaborate with us, or simply chat.
© 2024 RareGeniX Consulting Limited | All Rights Reserved